Dr. Scott Gregory Westphal, MD

Dr. Westphal practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Westphal's NPI, 1093031981, was assigned on April 16, 2010. Dr. Westphal graduated from University of Iowa, RJ & L Carver College of Medicine in 2010. Dr. Westphal holds Nebraska license 28433.

Dr. Westphal's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Westphal also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Westphal's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Westphal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Westphal practices. Vendor and product names are available with a free account.

Nephrology is Dr. Westphal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Westphal is licensed in Nebraska.

CMS data shows 283 Medicare services from Dr. Westphal across 6 procedure codes in 2024, for 131 Medicare patients. Medicare paid $21,431 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Westphal in 2024. The largest group is under 65, with 54 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 18% are also on Medicaid. Their average risk score is 6.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Westphal's median patient age at 56, with 46% women.

In 2024, Dr. Westphal wrote 1,655 Medicare Part D claims for 314 patients. 96% of them were for generic drugs. CMS names the drug for 1,472 of them, across 33 drugs with 11 or more claims each, at $47,514 in total drug cost. In 2023, CMS named 1,497 claims across 30 drugs.

Dr. Westphal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Westphal, published from 2015 to 2024. 2020 was the busiest year, with 6. The most frequent topics are Kidney Transplantation, Kidney Failure, Chronic and Tissue and Organ Procurement. Dr. Westphal has published most often in Clin Transplant. Dr. Westphal's most frequent co-authors are Clifford D. Miles, MD, Arika L. Hoffman, MD and Eric Donald Langewisch, MD.

Dmand AI links Dr. Westphal to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 22 general payments to Dr. Westphal from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $497.

Dr. Westphal graduated from University of Iowa, RJ & L Carver College of Medicine in 2010.